Subscribe to RSS
DOI: 10.1055/s-0028-1087104
The Use of Serial Human Chorionic Gonadotropin Levels to Establish a Viable or a Nonviable Pregnancy
Publication History
Publication Date:
29 September 2008 (online)
![](https://www.thieme-connect.de/media/srm/200805/lookinside/thumbnails/10.1055-s-0028-1087104-1.jpg)
ABSTRACT
Measurement of serial human chorionic gonadotropin (hCG) concentrations facilitates the diagnosis of normal or abnormal early gestation, as deviations from expected rates of rise or decline prompt intervention and/or treatment of abnormal pregnancies. Recently, the expected rise in hCG levels for normal intrauterine pregnancies (IUPs) was well characterized, and based on a 95% confidence interval, it was determined that the slowest rise in a normal IUP was 53% in 2 days. When the hCG level is decreasing, it is clear that the pregnancy is not viable. The management of such cases consists of observation or intervention. The rate of decline associated with nonviable pregnancies that resolved with expectant management has been described, with a faster decline observed with higher hCG levels at presentation. A rate of decline that is slower than 21 to 35% in 48 hours suggests the presence of retained trophoblastic tissue or an ectopic pregnancy and indicates the need for intervention to achieve a definitive diagnosis. While there is no consistent pattern of serial hCG levels characterizing ectopic pregnancies, the majority of patients ultimately diagnosed with ectopic pregnancy will exhibit rates of rise or decline that are outside the “normal” range as defined by the established curves.
KEYWORDS
Human chorionic gonadotropin - ectopic pregnancy - spontaneous abortion - multiple gestation - intrauterine pregnancy
REFERENCES
- 1 Speert H. Obstetric and gynecology milestones illustrated. New York, NY; Parthenon Publishing 1996: 222-227
- 2 Stewart B K, Nazar-Stewart V, Tiovola B. Biochemical discrimination of pathologic pregnancy from early, normal intrauterine gestation in symptomatic patients. Am J Clin Pathol. 1995; 103 386-390
- 3 Barnhart K T, Simhan H, Kamelle S A. Diagnostic accuracy of ultrasound above and below the beta-hCG discriminatory zone. Obstet Gynecol. 1999; 94 583-587
-
4 Boime I, Garcia-Campayo V, Hsueh A.
The glycoprotein hormones and their receptors . In: Barbieri RL Yen and Jaffe's Reproductive Endocrinology, 5th ed. Philadelphia, PA; Elsevier Saunders 2004: 75-92 - 5 Qu J, Thomas K. Prostaglandins stimulate the secretion of inhibin from human placental cells. J Clin Endocrinol Metab. 1993; 77 556-564
- 6 Lohstroh P, Overstreet J W, Stewart D R et al.. Secretion and excretion of human chorionic gonadotropin during early pregnancy. Fertil Steril. 2005; 83 1000-1011
- 7 Lohstroh P N, Overstreet J W, Stewart D R et al.. Hourly human chorionic gonadotropin secretion profiles during the peri-implantation period of successful pregnancies. Fertil Steril. 2007; 87 1413-1418
- 8 Csapo A, Pulkkinen M O, Wiest W G. Effects of luteectomy and progesterone replacement in early pregnant patients. Am J Obstet Gynecol. 1973; 115 759-765
- 9 Pittaway D E, Wentz A. Evaluation of early pregnancy by serial chorionic gonadotropin determination: a comparison of methods by receiver operating curve analysis. Fertil Steril. 1985; 43 529-533
- 10 Fritz M, Guo S. Doubling time of human chorionic gonadotropin (hCG) in early normal pregnancy: relationship to hCG concentration and gestational age. Fertil Steril. 1987; 47 584-589
- 11 Kadar N, Freedman M, Zacher M. Further observation on the doubling time of human chorionic gonadotropin in early asymptomatic pregnancy. Fertil Steril. 1990; 54 783-787
- 12 Check J H, Weiss R, Lurie D. Analysis of serum human chorionic gonadotrophin levels in normal singleton, multiple and abnormal pregnancies. Hum Reprod. 1992; 7 1176-1180
- 13 Kadar N, Romero R. Observations on the log human chorionic gonadotropin-time relationship in early pregnancy and its practical implication. Am J Obstet Gynecol. 1987; 157 73-78
- 14 Kadar N, Caldwell B V, Romero R. A method of screening for ectopic pregnancy and its indications. Obstet Gynecol. 1981; 58 162-166
- 15 Barnhart K T, Sammel M D, Rinaudo P F, Zhou L, Hummel A C, Guo W. Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol. 2004; 104 50-55
- 16 Clayton H B, Schieve L A, Peterson H B, Jamieson D J, Reynolds M A, Wright V C. Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol. 2006; 107 595-604
- 17 Confino E, Demir R H, Friberg J, Gleicher N. The predictive value of hCG beta subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer: an international collaborative study. Fertil Steril. 1986; 45 526-531
- 18 Zegers-Hochschild F, Altieri E, Fabres C, Fernandez E, Mackenna A, Orihuela P. Predictive value of human chorionic gonadotrophin in the outcome of early pregnancy after in-vitro fertilization and spontaneous conception. Hum Reprod. 1994; 9 1550-1555
- 19 Chung K, Sammel M D, Coutifaris C et al.. Defining the rise of serum HCG in viable pregnancies achieved through use of IVF. Hum Reprod. 2006; 21 823-828
- 20 Kohen P, Castro O, Palomino A et al.. The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase. J Clin Endocrinol Metab. 2003; 88 3421-3430
- 21 Kelly M P, Molo M W, Maclin V, Binor Z, Radwanska E. Human chorionic gonadotropin rise in normal and vanishing twin pregnancies. Fertil Steril. 1991; 56 221-224
- 22 Deslypere J P, Verdonck L, Vermeulen A. Fat tissue: a steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab. 1985; 61 564-570
- 23 Tong S, Wallace E, Rombauts L. Association between low day 16 hCG and miscarriage after proven cardiac activity. Obstet Gynecol. 2006; 107 300-304
- 24 Porat S, Savchev S, Bdolah Y et al.. Early serum B-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome. Fertil Steril. 2007; 88 82-89
- 25 Marrs R P, Kletzky O A, Howard W F, Mishell D R. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol. 1979; 135 731-736
- 26 Steier J A, Bergsjo P, Myking O L. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy. Obstet Gynecol. 1984; 64 391-394
- 27 Aral K, Gurkan Zorlu C, Gokmen O. Plasma human chorionic gonadotropin levels after induced abortion. Adv Contracept. 1996; 12 11-14
- 28 Stovall T G, Ling F W, Carson S A, Buster J E. Nonsurgical diagnosis and treatment of tubal pregnancy. Fertil Steril. 1990; 54 537-538
- 29 Barnhart K, Sammel M, Chung K, Zhou L, Hummel A C, Guo W. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol. 2004; 104 975-981
- 30 Chung K, Sammel M, Zhou L, Hummel A, Guo W, Barnhart K. Defining the curve when initial levels of human chorionic gonadotropin in patients with spontaneous abortions are low. Fertil Steril. 2006; 85 508-510
- 31 Silva C, Sammel M, Zhou L, Gracia C, Hummel A, Barnhart K. Human chorionic gonadotropin profile for women with ectopic pregnancy. Obstet Gynecol. 2006; 107 605-610
- 32 Seeber B E, Barnhart K T. Suspected ectopic pregnancy. Obstet Gynecol. 2006; 107 399-413
- 33 Condous G, Kirk E, Van Calster B, Van Huffel S, Timmerman D, Bourne T. Failing pregnancies of unknown location: a prospective evaluation of the human chorionic gonadotrophin ratio. BJOG. 2006; 113 521-527
- 34 Barnhart K T, Katz I, Hummel A, Gracia C R. Presumed diagnosis of ectopic pregnancy. Obstet Gynecol. 2002; 100 505-510
- 35 Ailawadi M, Lorch S A, Barnhart K T. Cost effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage. Fertil Steril. 2005; 83 376-382
- 36 Gracia C R, Barnhart K. Diagnosing ectopic pregnancy: decision analysis comparing six strategies. Obstet Gynecol. 2001; 97 464-470
- 37 Cole L. Phantom hCG and phantom choriocarcinoma. Gynecol Oncol. 1998; 71 325-329
- 38 Rotmensch S, Cole L. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet. 2000; 355 712-715
- 39 Elliott M M, Kardana A, Lustbader J W, Cole L A. Carbohydrate and peptide structure of the alpha- and beta- subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine. 1997; 7 15-32
- 40 Cole L, Shahabi S, Oz U, Bahado-Singh R, Mahoney M. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay; a new basis for gestational Down syndrome screening. Clin Chem. 1999; 45 2109-2119
- 41 Kovalevskaya G, Birken S, Kakuma T et al.. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies; preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol. 2002; 172 497-506
- 42 Kovalevskaya G, Birken S, Kakuma T, O'Connor J. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J Endocrinol. 1999; 161 99-106
- 43 Sasaki Y, Ladner D, Cole L. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. 2008; 89 1781-1786
Karine ChungM.D.
Assistant Professor of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Southern California, Keck School of Medicine
1240 North Mission Road, Room 8K9, Los Angeles, CA 90033
Email: karinech@usc.edu